... to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. 2023 Antibiotic prophylaxis Fluoroquinolones Acute leukemia Neutropenia Chemotherapy Therapy for acute leukemia (AL) requires the use of intensive remission...

... Leukemia Myelodysplastic syndrome Chemotherapy Targeted therapy Sweet syndrome (SS) is a neutrophilic dermatosis characterized by the abrupt eruption of painful edematous and erythematous papules. While it can be idiopathic or associated with autoimmune or inflammatory conditions and medication...

... Group T-cell acute lymphoblastic leukemia (T-ALL) is a rare disease usually treated with intensive, high-dose consolidation chemotherapy followed by an allotransplant in a substantial number of patients. The data of the RALL-2009 study on 125 adult T-ALL patients suggest that similar total chemotherapy...

...Tali Siegal; Osnat Bairey Primary central nervous system (CNS) lymphoma is an aggressive brain tumor sensitive to chemotherapy and radiotherapy. Its incidence has increased in the elderly, and they account for the majority of patients. The median survival of patients older than 70 years did...

... or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Chemotherapy Non-Hodgkin’s lymphoma Progression-free survival...

.... Chemotherapy 18 F-fluorodeoxyglucose-positron emission tomography Primary bone lymphoma Radiotherapy Primary bone lymphoma (PBL) is a rare disease. PBL comprises less than 1% of all malignant lymphomas, approximately 5% of extranodal non-Hodgkin's lymphomas and 7% of primary bone tumors [ 1 ]. PBL...

... in treating NLPHL still needs clarification. Methods: We retrospectively reviewed the outcome of 23 patients with NLPHL treated with rituximab alone or in combination with chemotherapy and/or radiotherapy as part of their first- or second-line treatment. Results: The median follow-up of the whole group was 67...

... factors such as type of treatment (chemotherapy vs. autologous vs. allogeneic HSCT) were also included. All p values were 2-sided and were considered significant if <0.05. All statistical analyses were performed using STATA 12 (StataCorp LP, College Station, Tex., USA). Antidepressant drugs were...

... outcome is unsatisfactory. We compared up-front allogeneic hematopoietic cell transplantation (HCT) to induction chemotherapy (IC) as an initial treatment in patients with s-AML arising from MDS. This retrospective study included 85 patients who were diagnosed with s-AML arising from MDS; 11 patients...

...(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Acute leukemia (adult) Allogeneic bone marrow transplantation Chemotherapy Over half of adults with acute...

... patients with haematological malignancies for a number of reasons. Firstly, Se compounds have direct cytotoxic activity against leukaemia and lymphoma cells and also sensitize them to chemotherapy drugs [ 4 ]. Moreover, there is substantial preclinical, and early clinical, research indicating that Se...

... = 11, 50%) and the most common histology was diffuse large B-cell lymphoma. 21 patients received chemotherapy as initial therapy and 16 received combined chemoradiation. 81.8% of the patients (n = 18) achieved complete remission. 5-year survival rate was 86.3% and overall survival was found...

... lymphoblastic leukemia is unsatisfactory in adults due to disease and patient-related factors and probably because adult chemotherapy regimens are weaker than pediatric protocols. Worries about inadequacy of adult regimens urged many hematologists, including us, to reconsider their routine treatment practices...

... marrow involvement Splenomegaly Chemotherapy Follicular lymphoma Although the spleen is frequently involved in B cell lymphomas, marked splenomegaly as a main presenting sign in follicular lymphoma (FL) is rare. Thus, FL presenting with splenomegaly as the only involvement should...

... manifestations. 29 08 2011 26 10 2011 12 1 2012 In our case, even though the tumor was highly sensitive to chemotherapy, the response duration time was short, and the disease progressed rapidly after relapse with an overall survival time of 15 months. Review of the literature illustrates...

.... This report concerns the effect of cyclosporin A (CsA) on chemotherapy-refractory AITL. A 68-year-old female with AITL with systemic symptoms, such as high fever, skin rash andgeneralized lymphadenopathy, was initially treated with conventional cytotoxic chemotherapies using alkylators, anthracyclines...

... leukemia (NT-AML). They showed that these patients exhibited erythroblastic and/or megakaryocytic dysplasia (EMD) in bone marrow smears and had poor overall survival after chemotherapy (median 4 months, range 0.1–32) [ 1 ]. Other smaller series of NT-AML cases showed similarly poor survival, the longest...

.... We evaluated the prognostic significance of the pretreatment serum level of 15-kDa granulysin in patients with diffuse large B cell lymphoma (DLBCL). Patients and Methods: A retrospective analysis was conducted on 88 DLBCL patients treated homogeneously with standard chemotherapy. The granulysin...

... with current chemotherapy regimens, 50% die of the disease [ 1 ]. The CHOP regimen (cyclophosphamide, doxorubicin, vincristine and prednisolone) was the standard treatment for both younger and older patients with DLBCL, but it induced complete responses in only 40–50% of elderly patients, with 3-year overall...

... transplantation or receiving chemotherapy. However, there have been few reports on the incidence and risk factors of HVIs in diffuse large B-cell lymphoma (DLBL) patients treated with rituximab combined chemotherapy. Methods: We analyzed 270 patients who were newly diagnosed with DLBL. All of the patients had...